Literature DB >> 25076084

Needling versus liquid nitrogen cryotherapy for the treatment of pedal warts a randomized controlled pilot study.

Daniel J Cunningham, Jessica T Brimage, Reza N Naraghi, Virginia M Bower.   

Abstract

BACKGROUND: We hypothesized that needling of a pedal wart creates local inflammation and a subsequent cell-mediated immune response (CMIR) against human papillomavirus. The primary objective of this study was to investigate whether needling to induce a CMIR against human papillomavirus is an effective treatment for pedal warts compared with liquid nitrogen cryotherapy. A secondary objective was to investigate whether the CMIR induced by needling is effective against satellite pedal warts.
METHODS: Eligible patients with pedal warts were randomly allocated to receive either needling or liquid nitrogen cryotherapy. Only the primary pedal wart was treated during the study. Follow-up was 12 weeks, with outcome assessments made independently under blinded circumstances.
RESULTS: Of 37 patients enrolled in the study, 18 were allocated to receive needling and 19 to receive liquid nitrogen cryotherapy. Regression of the primary pedal wart occurred in 64.7% of the needling group (11 of 17) and in 6.2% of the liquid nitrogen cryotherapy group (1 of 16) (P =  .001). No significant relationship was found between needling of the primary pedal wart and regression of satellite pedal warts (P = .615) or complete pedal wart regression (P = .175). There was no significant difference in pain, satisfaction, or cosmesis between the two groups.
CONCLUSIONS: The regression rate of the primary pedal wart was significantly higher in the needling group compared with the liquid nitrogen cryotherapy group.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25076084     DOI: 10.7547/0003-0538-104.4.394

Source DB:  PubMed          Journal:  J Am Podiatr Med Assoc        ISSN: 1930-8264


  2 in total

1.  Cidofovir Intralesional Injection for Recalcitrant Common Warts: A Comparison with Sodium Tetradecyl Sulfate Intralesional Injection.

Authors:  Byung Ho Oh
Journal:  Ann Dermatol       Date:  2020-06-30       Impact factor: 1.444

2.  EVerT2-needling versus non-surgical debridement for the treatment of verrucae: study protocol for a single-centre randomised controlled trial.

Authors:  Farina Hashmi; David Torgerson; Caroline Fairhurst; Sarah Cockayne; Kerry Bell; Michelle Cullen; Michael Harrison-Blount
Journal:  BMJ Open       Date:  2015-11-24       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.